NE HEALTH BUREAU
CHENNAI, JULY 27
Apollo Specialilty Hospitals, Vanagaram on Saturday (July 24, 2021) launched the Quaternary Care, Level FOUR Epilepsy Care Center to help people living with epilepsy.
⇑The advanced epilepsy care centre was launched by Minister for Milk and Dairy Development S M Nasar in the presence of Dr Alby John Varghese, District Collector, Tiruvallur.
This level FOUR Epilepsy Care Centre has been launched by Apollo Speciality Hospitals Vanagaram to localize (finding the lesion location in the brain), classify (Type of seizure), accelerate therapies to control seizures, further evaluate & offer higher level of care including Epilepsy Surgeries.
Epilepsy affects about 1.2% of the total world population 1 in 25 people have chance for developing seizure in their lifetime, In India it is estimated more than 10 million persons with epilepsy and in about 70% of people with epilepsy, seizures can be controlled with 1 or 2 anti-Epileptic drugs. The majority of people with seizures can be managed effectively by the treating physician, but 30% or so that have difficult to control seizures and do not respond to standard treatment require the nextlevel of care at an epilepsy care center.
The epilepsy centre will have a dedicated team consisting of experienced Neurologists, Pediatric Neurologists, Epileptologists, Neurosurgeons, Neuropsychologists, Neuro-technicians, Rehab specialist and staff nurses who provide their experience and care for the patients.
Speaking during the launch of the centre Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Group, said, “At Apollo we have always strived towards brining global standard healthcare to our patients. We have been continuously investing in talent, technology and patient care. This level FOUR Epilepsy centre launched today will enable positive clinical outcomes in patients who have been suffering with long term epilepsy. “
The Level FOUR Epilepsy Care Centre will enable early referral and treatment of patients with persistent seizures, which has potential to irreversibly damage the brain, and offer hope to this select group of patients enabling them to live better.
